CUBT (Curative Biotechnology) Interest Expense: $-1.37 Mil (TTM As of Mar. 2023)


What is Curative Biotechnology Interest Expense?

Curative Biotechnology CUBT +19.71% Interest Expense is $-1.37 Mil as of Mar. 2023.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Curative Biotechnology's interest expense for the three months ended in Mar. 2023 was $ -0.31 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.37 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Curative Biotechnology's Operating Income for the three months ended in Mar. 2023 was $ -0.66 Mil. Curative Biotechnology's Interest Expense for the three months ended in Mar. 2023 was $ -0.31 Mil. Curative Biotechnology did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curative Biotechnology  (OTCPK:CUBT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curative Biotechnology's Interest Expense for the three months ended in Mar. 2023 was $-0.31 Mil. Its Operating Income for the three months ended in Mar. 2023 was $-0.66 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2023 was $0.00 Mil.

Curative Biotechnology's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Curative Biotechnology did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Curative Biotechnology Interest Expense Historical Data

* Premium members only.

The historical data trend for Curative Biotechnology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Interest Expense Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Interest Expense
Get a 7-Day Free Trial -0.02 -0.02 -0.04 -0.18 -1.17

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.32 -0.34 -0.40 -0.31

Curative Biotechnology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-1.37 Mil mean?
Curative Biotechnology (CUBT) has a Interest Expense of $-1.37 Mil as of Mar. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Curative Biotechnology and its competitors.
Is Curative Biotechnology's Interest Expense too high?
Curative Biotechnology's current Interest Expense is $-1.37 Mil.
How does Curative Biotechnology's Interest Expense compare to ORGS and SNSE?
Curative Biotechnology's Interest Expense of $-1.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Curative Biotechnology and its competitors. Curative Biotechnology's current Interest Expense is $-1.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biotechnology stock overvalued right now?
Curative Biotechnology (CUBT) has a current Interest Expense of $-1.37 Mil. The current Interest Expense is $-1.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Curative Biotechnology (CUBT), the current Interest Expense is $-1.37 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biotechnology Business Description

Address 3801 PGA Boulevard, Suite 600, Palm Beach Gardens, FL, USA, 33410
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is identifying, acquiring, and developing disease-modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform.